BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA
Bristol-myers Squibb Company Complete list of announcements declared & dividend announcements by Bristol-myers Squibb Company BMY
Bristol-myers Squibb Company BMY listed on USA and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Bristol-myers Squibb Company BMY
Bristol Myers' (BMY) Opdivo Combos Get FDA Nod for ESCC
Bristol Myers Squibb BMY announced that the FDA has approved Opdivo (nivolumab) combinations for yet another indication.
Announcement as on 30 May 2022
Nektar, Bristol Myers Squibb end clinical development of combination therapy including Opdivo
Shares of Nektar Therapeutics Inc. were down 35.9% in trading on Monday after the company announced Friday that it halted development of bempegaldesleukin in combination with Bristol Myers Squibb's Opdivo. The combination was being tested in several type
Announcement as on 18 April 2022
Bristol Myers' (BMY) Opdivo Data Positive for Neoadjuvant NSCLC
Bristol Myers BMY announced encouraging results from the phase III CheckMate -816 study in patients with resectable non-small cell lung cancer (NSCLC).
Announcement as on 12 April 2022
Bristol Myers Squibb (BMY) Stock Moves -0.85%: What You Should Know
Bristol Myers Squibb (BMY) closed the most recent trading day at .77, moving -0.85% from the previous trading session. This change was narrower than the S&P 500's daily loss of 2.95%. Meanwhile, the Dow lost 2.37%, and the Nasdaq, a tech-heavy index, lo
Announcement as on 07 March 2022
Bristol Myers Squibb (BMY) Stock Moves -0.85%: What You Should Know
Bristol Myers Squibb (BMY) closed the most recent trading day at .77, moving -0.85% from the previous trading session. This change was narrower than the S&P 500's daily loss of 2.95%. Meanwhile, the Dow lost 2.37%, and the Nasdaq, a tech-heavy index, lo
Announcement as on 07 March 2022
Announcements by Bristol-myers Squibb Company first page | Next page | Prev page |
BMY Bristol-myers Squibb Company current price & indicator signals
Recent prices of BMY Bristol-myers Squibb Company are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 30 Tue Jun 2026 | 57.61 | 57.27 to 58.88 | -1.61% | 0.5 times |
| 29 Mon Jun 2026 | 58.55 | 57.15 to 58.58 | 1.79% | 0.52 times |
| 26 Fri Jun 2026 | 57.52 | 55.40 to 57.74 | 3.85% | 2.11 times |
| 25 Thu Jun 2026 | 55.39 | 55.02 to 56.19 | 0.65% | 1.4 times |
| 24 Wed Jun 2026 | 55.03 | 54.78 to 56.59 | -0.9% | 0.87 times |
| 23 Tue Jun 2026 | 55.53 | 54.96 to 55.94 | 1.52% | 0.92 times |
| 22 Mon Jun 2026 | 54.70 | 53.99 to 54.73 | 1.28% | 1.4 times |
| 18 Thu Jun 2026 | 54.01 | 53.44 to 55.49 | -2.3% | 0.75 times |
| 17 Wed Jun 2026 | 55.28 | 55.01 to 56.21 | -1.18% | 0.79 times |
| 16 Tue Jun 2026 | 55.94 | 55.45 to 56.62 | -0.59% | 0.63 times |
| 15 Mon Jun 2026 | 56.27 | 56.01 to 57.24 | -1.51% | 0.6 times |
| 12 Fri Jun 2026 | 57.13 | 56.77 to 57.60 | 0.39% | 0.69 times |
Videos related to: BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


